Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Rocakinogene Sifuplasmid
Hepatocellular Carcinoma
National Cancer Institute (NCI)P1C (37)
Autologous Hucd19 Car T Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)P1/2C (37)
Dordaviprone
Colorectal Carcinoma
National Cancer Institute (NCI)P1C (36)
Grt-R904
Breast Cancer
National Cancer Institute (NCI)P1C (36)
Grt-R904
Ovarian Cancer
National Cancer Institute (NCI)P1C (36)
Autologous Hucd19 Car T Cells
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P1/2C (36)
Revumenib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P1C (35)
Cabozantinib
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)P1C (34)
Egfr/B7H3 Car-T
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1C (34)
Hepatitis A Vaccine
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2C (33)
Cabozantinib
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)P1C (33)
Magrolimab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)P1C (33)
Magrolimab
Follicular Lymphoma
National Cancer Institute (NCI)P1C (33)
Magrolimab
Mantle Cell Lymphoma
National Cancer Institute (NCI)P1C (33)
Magrolimab
Marginal Zone Lymphoma
National Cancer Institute (NCI)P1C (33)
Vismodegib
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2C (32)
Vismodegib
Melanoma
National Cancer Institute (NCI)P2C (32)
Vismodegib
Skin Carcinoma
National Cancer Institute (NCI)P2C (32)
cd22 car-transduced t cells
Precursor B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P1C (32)
Vismodegib
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2D (31)
Vismodegib
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2D (31)
Vismodegib
Glioma
National Cancer Institute (NCI)P2D (31)
Vismodegib
Lung Carcinoma
National Cancer Institute (NCI)P2D (31)
Vismodegib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2D (31)
Sasanlimab
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P1/2D (31)
Showing 3201 to 3225 of 3,272 assets
PreviousPage 129 of 131Next